Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma
Clinical trial NCT00438984 · COMPLETED
Trial details
- NCT number
- NCT00438984
- Sponsor
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2011-01-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.